Dr. Thomas E. Brothers, MD

Dr. Brothers practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Brothers' NPI, 1619081197, was assigned on August 19, 2006. Dr. Brothers graduated from University Of Michigan Medical School in 1983. Dr. Brothers holds South Carolina license 15429.

Dr. Brothers' primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Brothers' primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Brothers is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Brothers to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brothers practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Brothers' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Brothers is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Brothers' licenses on file in 2 states: South Carolina and Michigan.

Dmand AI lists carotid revascularization, heart device and aorta surgery, leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Brothers treats.

CMS data shows 524 Medicare services from Dr. Brothers across 9 procedure codes in 2024, for 441 Medicare patients. Medicare paid $20,507 for them.

CMS counts 441 Medicare patients who saw Dr. Brothers in 2024. The largest group is 65 to 74, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brothers' median patient age at 73, with 42% women.

In 2024, Dr. Brothers wrote 83 Medicare Part D claims for 18 patients. 78% of them were for generic drugs. CMS names the drug for 68 of them, across 4 drugs with 11 or more claims each, at $14,472 in total drug cost. In 2023, CMS named 60 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Brothers for performance year 2024, reported as part of a group. Dr. Brothers accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brothers as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Brothers, published from 2003 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Amputation, Surgical, Vascular Patency and Endovascular Procedures. Dr. Brothers has published most often in J Vasc Surg. Dr. Brothers' most frequent co-authors are Jacob G. Robison, MD, Bruce Elliott, MD and Ryan William King, MD.

Dmand AI links Dr. Brothers to 2 clinical trials. Conditions studied include Chronic Limb-Threatening Ischemia, Gangrene and Peripheral Arterial Disease.

CMS Open Payments shows 16 general payments to Dr. Brothers from 10 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $566. It also lists 4 research payments totaling $2,463 in 2020.

Dmand AI lists 25 awards for Dr. Brothers, most recently CMS Stage 1 EHR in 2013.

Dr. Brothers graduated from University Of Michigan Medical School in 1983. Dr. Brothers is a member of ACS.

Dr. Brothers is in network with 17 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.